NEWS & PERSPECTIVES

Psychedelics News

Curated updates on microdosing, research, policy, and community.

The latest

2026-08-19 • Medical Xpress (Psychedelics)

World's largest psilocybin brain-imaging study maps how context reshapes psychedelic effects

A landmark five-year study by Monash University has found psychedelics reorganize brain patterns, giving clinicians powerful new insights into their therapeutic potential.

2026-08-19 • Medical Xpress (Psychedelics)

Study finds sustained benefit for people using Oregon psilocybin services

People participating in an Oregon Health & Science University-led study of state-regulated psilocybin services reported relief from symptoms of anxiety, depression and post-traumatic stress disorder—with almost two-th...

2026-08-19 • DoubleBlind Magazine

Would You Recognize Abuse in Ceremony? If So, What Do You Do?

"The Psychedelic Seeker's Guide" dives into abusive practitioners and what you should do if you witness abuse in psychedelic settings. [...] Read More... The post Would You Recognize Abuse in Ceremony? If So, What Do ...

2026-08-19 • Blossom Pulse: Papers

Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services

This cohort study (n=346) of clients using Oregon's state-regulated psilocybin services, who received a mean dose of 31.9 mg, found reduced rates of moderate-to-severe depression, anxiety and PTSD symptoms at three mo...

2026-08-19 • Blossom Pulse: Papers

Psychedelics align brain activity with context

This brain imaging study (n=62) used fMRI and EEG to examine brain activity before and after psilocybin during rest, meditation, music and films. Psilocybin reorganised brain activity into structured patterns that ref...

2026-08-18 • Psychedelics Today

Weekly Psychedelic Policy Briefing – August 16, 2026

Resilient Pharmaceuticals has resubmitted its New Drug Application for MDMA-assisted therapy for PTSD, without the new Phase 3 trial the FDA asked for. Canada funds a C$24 million cannabis and brain health consortium,...

2026-08-18 • Psychedelic Alpha

Paving the Way: Husseini Manji on Spravato’s Lessons for Psychedelic Drug Development

Dr. Husseini Manji’s affiliations are quite the laundry list: a professor of psychiatry at the University of Oxford with adjunct and visiting positions at Yale and Duke, as well as serving as co-chair of the UK govern...

2026-08-18 • Medical Xpress (Psychedelics)

Psychedelic exposure during adolescence disrupts a brain circuit linked to lasting social avoidance in rats

Psychedelics, drugs that alter people's perceptions, mood and thoughts, have recently shown promise for the treatment of some psychiatric disorders. Yet many psychedelic drugs remain controlled substances in most coun...

2026-08-18 • Psychedelic Invest

SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million

SciSparc Invests C$2.7 million and holds approximately 44.6% of NeuroThera’s issued and outstanding common shares following the financing TEL AVIV, Israel, Aug. 18, 2026 (GLOBE NEWSWIRE) -- SciSparc…

2026-08-18 • Blossom Pulse: Papers

Tuning in together: LSD enhances inter-brain synchrony and felt connectedness in romantic couples

This randomised, double-blind, placebo-controlled crossover study (n=25 couples) found that LSD (50 μg) increased feelings of love, closeness, trust and being in sync, while reducing loneliness, in healthy romantic pa...

2026-08-17 • Microdosing Institute

Altered ‘state’ vs Altered ‘sense of self’

Psychedelic culture has given us a powerful image of transformation: the self dissolves, the familiar world disappears, and somehow we return, from the other side, changed. It is the territory associated with the larg...

Microdosing
2026-08-17 • Psychedelic Invest

Definium Therapeutics Announces New Employee Inducement Grants

NEW YORK, August 17, 2026--Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address…

2026-08-17 • The Microdose (Berkeley)

What’s the difference between recreational and therapeutic psychedelic use? 5 Questions with experimental psychologist Harriet de Wit

De Wit discusses the difficulty of finding out what a drug does, outside of its context.

2026-08-17 • DoubleBlind Magazine

World Ayahuasca Forum Brings Ancestral Intelligence to Spain

PLUS, an interview with an iconic Grateful Dead artist, ayahuasca and loneliness, and Puerto Rico's executive order. [...] Read More... The post World Ayahuasca Forum Brings Ancestral Intelligence to Spain appeared fi...